id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0028-0003,FDA,FDA-2011-D-0028,Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions,Rule,Final Rule,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2011-12-30T14:31:25Z,2011-33588,0,0,0900006480f8b788
FDA-2011-N-0003-0056,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs: Ivermectin Topical Solution,Rule,Final Rule,2011-12-29T05:00:00Z,2011,12,2011-12-29T05:00:00Z,,2011-12-29T13:58:17Z,2011-33382,0,0,0900006480f8acdf
FDA-2007-N-0265-0007,FDA,FDA-2007-N-0265,Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers; Correction,Rule,Correction,2011-12-28T05:00:00Z,2011,12,2011-12-28T05:00:00Z,,2011-12-28T20:10:32Z,2011-33183,0,0,0900006480f8a284
FDA-2011-N-0003-0054,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Monensin,Rule,Final Rule,2011-12-21T05:00:00Z,2011,12,2011-12-21T05:00:00Z,,2011-12-21T22:06:14Z,2011-32427,0,0,0900006480f87099
FDA-2011-N-0003-0055,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Zinc Gluconate,Rule,Final Rule,2011-12-21T05:00:00Z,2011,12,2011-12-21T05:00:00Z,,2011-12-21T22:32:43Z,2011-32591,0,0,0900006480f87170
FDA-2011-N-0003-0052,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Cyclosporine,Rule,Final Rule,2011-12-20T05:00:00Z,2011,12,2011-12-20T05:00:00Z,,2011-12-20T15:34:59Z,2011-32526,0,0,0900006480f864a7
FDA-2011-N-0898-0001,FDA,FDA-2011-N-0898,Applications for Food and Drug Administration Approval to Market New Drug: Revision of Postmarketing Reporting Requirements; Discontinuance,Rule,Notice of Interim Rule,2011-12-19T05:00:00Z,2011,12,2011-12-19T05:00:00Z,2012-02-18T04:59:59Z,2011-12-19T16:11:43Z,2011-32354,0,0,0900006480f85979
FDA-2011-N-0003-0048,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Estriol,Rule,Final Rule,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T18:28:06Z,2011-32214,0,0,0900006480f84681
FDA-2011-N-0003-0050,FDA,FDA-2011-N-0003,"Ophthalmic and Topical Dosage Form New Animal Drugs: Hydrocortisone Aceponate, Miconazole Nitrate, and Gentamicin Sulfate Otic Suspension",Rule,Final Rule,2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-16T19:26:27Z,2011-32226,0,0,0900006480f846b9
FDA-2011-N-0003-0044,FDA,FDA-2011-N-0003,New Animal Drugs for Use in AnimalFeeds: Tilmicosin,Rule,Final Rule,2011-12-09T05:00:00Z,2011,12,,,2011-12-09T16:06:45Z,2011-31613,0,0,0900006480f7edc7
FDA-2011-N-0003-0040,FDA,FDA-2011-N-0003,Ophthalmic and Topical Dosage Form New Animal Drugs; Eprinomectin,Rule,Final Rule,2011-11-25T05:00:00Z,2011,11,2011-11-25T05:00:00Z,,2011-11-25T14:20:46Z,2011-30328,0,0,0900006480f73670
FDA-2011-N-0003-0039,FDA,FDA-2011-N-0003,"Animal Drugs, Feeds, and Related Products; Eprinomectin; N-Methyl-2-Pyrrolidone",Rule,Final Rule,2011-11-25T05:00:00Z,2011,11,,,2011-11-25T14:23:01Z,2011-30329,0,0,0900006480f73650
FDA-2009-N-0025-0007,FDA,FDA-2009-N-0025,Animal Food Labeling; Declaration of Certifiable Color Additives,Rule,Final Rule,2011-11-17T05:00:00Z,2011,11,2011-11-17T05:00:00Z,,2015-03-25T11:53:37Z,2011-29701,0,0,0900006480f6e620
FDA-2011-N-0003-0037,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin; Tylosin,Rule,Final Rule,2011-10-20T04:00:00Z,2011,10,2011-10-20T04:00:00Z,,2011-10-20T14:02:09Z,2011-27139,0,0,0900006480f56b31
FDA-1993-N-0259-0024,FDA,FDA-1993-N-0259,Beverages; Bottled Water Quality Standard: Establishing an Allowable Level for di(2-ethylhexyl)phthalate - Notice of Final Rule Effective 4/16/2012,Rule,Final Rule,2011-10-19T04:00:00Z,2011,10,2011-10-19T04:00:00Z,,2012-01-31T15:11:52Z,2011-26707,0,0,0900006480f55cfd
FDA-2011-N-0003-0035,FDA,FDA-2011-N-0003,New Animal Drugs for Use in Animal Feeds: Melengestrol; Monensin,Rule,Final Rule,2011-09-30T04:00:00Z,2011,9,2011-09-30T04:00:00Z,,2011-09-30T13:05:07Z,2011-25220,0,0,0900006480f45b6a
FDA-2009-C-0543-0005,FDA,FDA-2009-C-0543,Listing of Color Additives Exempt from Certification: Reactive Blue 69; Confirmation of Effective Date,Rule,Final Rule,2011-09-27T04:00:00Z,2011,9,2011-09-27T04:00:00Z,,2012-03-24T19:33:33Z,2011-24795,0,0,0900006480f35047
FDA-2011-N-0011-0001,FDA,FDA-2011-N-0011,"Environmental Impact Considerations, Food Additives, and Generally Recognized as Safe Substances: Technical Amendments",Rule,Final Rule,2011-09-26T04:00:00Z,2011,9,2011-09-26T04:00:00Z,,2011-09-26T14:45:43Z,2011-24455,0,0,0900006480f2be2f
FDA-2011-N-0003-0033,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Tylosin,Rule,Final Rule,2011-09-23T04:00:00Z,2011,9,2011-09-23T04:00:00Z,,2011-09-23T13:49:15Z,2011-24461,0,0,0900006480f28536
FDA-2011-N-0003-0031,FDA,FDA-2011-N-0003,New Animal Drugs: Gamithromycin,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:38:18Z,2011-23874,0,0,0900006480f22065
FDA-2011-N-0003-0030,FDA,FDA-2011-N-0003,Tolerances for Residues of New Animal Drugs in Food: Progesterone,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:31:42Z,2011-23867,0,0,0900006480f220a7
FDA-2011-N-0003-0028,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Ivermectin,Rule,Final Rule,2011-09-19T04:00:00Z,2011,9,2011-09-19T04:00:00Z,,2011-09-19T16:03:53Z,2011-23865,0,0,0900006480f22114
FDA-2011-N-0002-0099,FDA,FDA-2011-N-0002,Advisory Committee; Change of Name and Function: Technical Amendment,Rule,Final Rule,2011-08-30T04:00:00Z,2011,8,2011-08-30T04:00:00Z,,2011-08-30T14:34:08Z,2011-22105,0,0,0900006480f08cf5
FDA-2011-N-0003-0027,FDA,FDA-2011-N-0003,"New Animal Drugs: Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, etc.; Correcting Amendments",Rule,Correction,2011-08-25T04:00:00Z,2011,8,,,2011-08-25T13:40:34Z,2011-21721,0,0,0900006480eee4b8
FDA-2004-N-0061-0056,FDA,FDA-2004-N-0061,See FDA-2004-N-0061-0002,Rule,Final Rule,2011-08-22T04:00:00Z,2011,8,2011-08-22T04:00:00Z,,2011-08-22T17:51:39Z,,0,0,0900006480ee8af2
FDA-2011-M-0570-0001,FDA,FDA-2011-M-0570,Medical Devices: Ophthalmic Devices; Classification of the Eyelid Thermal Pulsation System,Rule,Final Rule,2011-08-19T04:00:00Z,2011,8,,,2011-08-19T18:02:44Z,2011-21195,0,0,0900006480ee5693
FDA-2010-N-0412-0004,FDA,FDA-2010-N-0412,Effective Date of Requirement for Premarket Approval for Three Class III Preamendments Devices,Rule,Final Rule,2011-08-16T04:00:00Z,2011,8,2011-08-16T04:00:00Z,,2012-03-24T19:34:54Z,2011-20664,0,0,0900006480ee2241
FDA-2011-N-0003-0026,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Change of Sponsor; Chlortetracycline; Sulfamethazine,Rule,Final Rule,2011-08-11T04:00:00Z,2011,8,,,2011-08-11T13:46:29Z,2011-20404,0,0,0900006480edde3b
FDA-2010-N-0429-0002,FDA,FDA-2010-N-0429,Immunology and Microbiology Devices: Reclassification of the Herpes Simplex Virus Serological Assay Device,Rule,Final Rule,2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2012-03-24T19:30:33Z,2011-20115,0,0,0900006480edbab0
FDA-2011-N-0003-0025,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor; Moxidectin,Rule,Final Rule,2011-08-09T04:00:00Z,2011,8,2011-08-09T04:00:00Z,,2011-08-09T14:46:08Z,2011-20182,0,0,0900006480edbacf
FDA-2011-N-0002-0083,FDA,FDA-2011-N-0002,Medical Imaging Drugs Advisory Committee; Re-establishment,Rule,Final Rule,2011-07-29T04:00:00Z,2011,7,,,2011-07-29T13:13:02Z,2011-19064,0,0,0900006480ecf3fc
FDA-1995-N-0031-0005,FDA,FDA-1995-N-0031,"Labeling for Bronchodilators to Treat Asthma; Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products, etc.",Rule,Final Rule,2011-07-26T04:00:00Z,2011,7,2011-07-26T04:00:00Z,,2011-07-28T14:06:22Z,2011-18347,0,0,0900006480ecb779
FDA-2011-N-0466-0001,FDA,FDA-2011-N-0466,Medical Devices; Neurological Devices: Classification of Repetitive Transcranial Magnetic Stimulation System,Rule,Final Rule,2011-07-26T04:00:00Z,2011,7,2011-07-26T04:00:00Z,,2011-07-26T16:20:14Z,2011-18806,0,0,0900006480ecb764
FDA-2007-N-0092-0002,FDA,FDA-2007-N-0092,Cardiovascular Devices: Classification of Electrocardiograph Electrodes,Rule,Final Rule,2011-07-21T04:00:00Z,2011,7,2011-07-21T04:00:00Z,,2011-07-21T13:23:56Z,2011-18391,0,0,0900006480ec80ef
FDA-2011-N-0499-0001,FDA,FDA-2011-N-0499,Medical Devices; General and Plastic Surgery Devices: Classification of the Focused Ultrasound Stimulator System for Aesthetic Use,Rule,Final Rule,2011-07-20T04:00:00Z,2011,7,2011-07-20T04:00:00Z,,2011-07-20T14:47:30Z,2011-18278,0,0,0900006480ec6fe2
FDA-2010-F-0103-0002,FDA,FDA-2010-F-0103,Food Additives Permitted for Human Consumption: Hydroxypropyl Cellulose,Rule,Final Rule,2011-07-15T04:00:00Z,2011,7,2011-07-15T04:00:00Z,2011-08-16T03:59:59Z,2011-07-18T20:20:35Z,2011-17928,0,0,0900006480ec321d
FDA-2011-N-0003-0023,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Amprolium,Rule,Final Rule,2011-07-12T04:00:00Z,2011,7,2011-07-12T04:00:00Z,,2011-07-12T14:34:01Z,2011-17465,0,0,0900006480ec062c
FDA-2011-N-0003-0022,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Name and Address,Rule,Final Rule,2011-07-11T04:00:00Z,2011,7,2011-07-11T04:00:00Z,,2011-07-11T13:50:45Z,2011-17292,0,0,0900006480ebef6a
FDA-2011-N-0003-0021,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs; Change of Sponsor,Rule,Final Rule,2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2011-07-08T19:06:59Z,2011-17151,0,0,0900006480ebcfab
FDA-2011-N-0033-0004,FDA,FDA-2011-N-0033,Oral Dosage Form New Animal Drugs; Change of Sponsor,Rule,,2011-07-08T00:00:00Z,2011,7,,,2011-07-08T16:56:38Z,,0,1,0900006480ebcd27
FDA-2011-N-0003-0020,FDA,FDA-2011-N-0003,New Animal Drugs: Change of Sponsor's Address,Rule,Final Rule,2011-07-06T04:00:00Z,2011,7,2011-07-06T04:00:00Z,,2011-07-06T18:50:24Z,2011-16845,0,0,0900006480eba135
FDA-2010-N-0646-0018,FDA,FDA-2010-N-0646,Tobacco Products: Exemptions From Substantial Equivalence Requirements,Rule,Final Rule,2011-07-05T04:00:00Z,2011,7,2011-07-05T04:00:00Z,,2012-03-24T19:31:41Z,2011-16766,0,0,0900006480eb965f
FDA-2011-N-0003-0019,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Amprolium,Rule,Final Rule,2011-07-01T04:00:00Z,2011,7,2011-07-01T04:00:00Z,,2011-07-01T14:40:14Z,2011-16501,0,0,0900006480eb82fd
FDA-2003-N-0212-0005,FDA,FDA-2003-N-0212,Notice of Final Rule re Medical Devices: Exception From General Requirements for Informed Consent,Rule,Final Rule,2011-06-24T04:00:00Z,2011,6,2011-06-24T04:00:00Z,,2015-12-07T16:16:06Z,2011-15816,0,0,0900006480eb3487
FDA-1997-N-0040-0086,FDA,FDA-1997-N-0040,Final Rule re Medical Devices: Neurological Devices; Clarification of Classification for Human Dura Mater; Technical Amendment,Rule,Final Rule,2011-06-24T04:00:00Z,2011,6,2011-06-24T04:00:00Z,,2016-02-02T16:10:30Z,2011-15817,0,0,0900006480eb3482
FDA-2010-N-0568-0251,FDA,FDA-2010-N-0568,Required Warnings for Cigarette Packages and Advertisements; Final Rule,Rule,Final Rule,2011-06-22T04:00:00Z,2011,6,2011-06-22T04:00:00Z,,2011-06-22T15:40:34Z,2011-15337,0,0,0900006480e8b8e4
FDA-1978-N-0018-0698,FDA,FDA-1978-N-0018,Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-the-Counter Human Use,Rule,Final Rule,2011-06-17T04:00:00Z,2011,6,2011-06-17T04:00:00Z,,2017-12-07T17:18:11Z,2011-14766,0,0,0900006480e52002
FDA-2011-N-0361-0001,FDA,FDA-2011-N-0361,"Medical Devices: Ear, Nose, and Throat Devices; Classification of the Wireless Air-Conduction Hearing Aid",Rule,Final Rule,2011-06-15T04:00:00Z,2011,6,2011-06-15T04:00:00Z,,2011-06-16T12:31:30Z,2011-14790,0,0,0900006480e50807
FDA-2006-D-0094-0005,FDA,FDA-2006-D-0094,Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls; Topical Oxygen Chamber for Extremities;  Availability; Correction,Rule,NCR-Notice of Correction,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2011-05-20T13:29:50Z,2011-12409,0,0,0900006480db8764
FDA-2006-N-0045-0003,FDA,FDA-2006-N-0045,Medical Devices; Reclassification of the Topical Oxygen Chamber for Extremities; Correction,Rule,NCR-Notice of Correction,2011-05-20T04:00:00Z,2011,5,2011-05-20T04:00:00Z,,2011-05-20T13:09:00Z,2011-12410,0,0,0900006480db88b0
FDA-2011-N-0003-0017,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Gonadotropin Releasing Factor-Diphtheria Toxoid Conjugate,Rule,NFR-Notice of Final Rule,2011-05-13T04:00:00Z,2011,5,2011-05-13T04:00:00Z,,2011-05-13T12:55:58Z,2011-11762,0,0,0900006480c79e08
FDA-2011-N-0179-0001,FDA,FDA-2011-N-0179,Information Required in Prior Notice of Imported Food,Rule,NIR-Notice of Interim Rule,2011-05-05T04:00:00Z,2011,5,2011-05-05T04:00:00Z,2011-08-04T03:59:59Z,2011-06-11T16:30:42Z,2011-10955,0,0,0900006480c3fc6b
FDA-2011-N-0197-0001,FDA,FDA-2011-N-0197,Criteria Used to Order Administrative Detention of Food for Human or Animal Consumption,Rule,NIR-Notice of Interim Rule,2011-05-05T04:00:00Z,2011,5,2011-05-05T04:00:00Z,2011-08-04T03:59:59Z,2011-06-11T16:30:42Z,2011-10953,0,0,0900006480c3fcd7
FDA-2009-C-0543-0002,FDA,FDA-2009-C-0543,Listing of Color Additives Exempt From Certification; Reactive Blue 69,Rule,NFR-Notice of Final Rule,2011-05-04T04:00:00Z,2011,5,2011-05-04T04:00:00Z,2011-06-04T03:59:59Z,2011-05-04T16:40:21Z,2011-10869,0,0,0900006480c3eb0f
FDA-2006-N-0045-0002,FDA,FDA-2006-N-0045,Medical Devices: Reclassification of the Topical Oxygen Chamber for Extremities,Rule,NFR-Notice of Final Rule,2011-04-25T04:00:00Z,2011,4,2011-04-25T04:00:00Z,,2011-04-25T19:09:56Z,2011-09899,0,0,0900006480c372bf
FDA-2011-N-0003-0015,FDA,FDA-2011-N-0003,Implantation or Injectable Dosage Form New Animal Drugs: Enrofloxacin,Rule,NFR-Notice of Final Rule,2011-04-22T04:00:00Z,2011,4,2011-04-22T04:00:00Z,,2011-04-22T13:02:12Z,2011-09765,0,0,0900006480c35d41
FDA-2011-N-0118-0001,FDA,FDA-2011-N-0118,Medical Devices; Obstetrical and Gynecological Devices: Classification of the Hemorrhoid Prevention Pressure Wedge,Rule,NFR-Notice of Final Rule,2011-04-15T04:00:00Z,2011,4,2011-04-15T04:00:00Z,,2011-04-15T13:49:53Z,2011-09141,0,0,0900006480c2dedd
FDA-2011-N-0188-0001,FDA,FDA-2011-N-0188,Medical Devices; General and Plastic Surgery Devices: Classification of the Low Level Laser System for Aesthetic Use,Rule,NFR-Notice of Final Rule,2011-04-14T04:00:00Z,2011,4,2011-04-14T04:00:00Z,,2011-04-14T16:36:11Z,2011-08944,0,0,0900006480c2c67b
FDA-2010-N-0099-0009,FDA,FDA-2010-N-0099,Revision of the Requirements for Constituent Materials,Rule,NFR-Notice of Final Rule,2011-04-13T04:00:00Z,2011,4,,,2011-04-13T17:06:13Z,2011-08885,0,0,0900006480c25e58
FDA-1998-F-0072-0004,FDA,FDA-1998-F-0072,"Irradiation in the Production, Processing, and Handling of Food",Rule,NFR-Notice of Final Rule,2011-04-13T04:00:00Z,2011,4,,,2011-04-14T15:23:49Z,2011-08815,0,0,0900006480c25ec1
FDA-2011-N-0003-0011,FDA,FDA-2011-N-0003,Oral Dosages Form New Animal Drugs: Robenacoxib,Rule,NFR-Notice of Final Rule,2011-04-05T04:00:00Z,2011,4,2011-04-05T04:00:00Z,,2011-04-05T13:54:22Z,2011-08053,0,0,0900006480c1bc56
FDA-2011-N-0160-0001,FDA,FDA-2011-N-0160,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of New Animal Drug Applications; Chorionic Gonadotropin; Cuprimyxin; Diethylcarbamazine; Levamisole; Nitrofurazone; Phenylbutazone; Pyrantel; Tylosin; Tylosin and Sulfamethazine",Rule,NFR-Notice of Final Rule,2011-03-31T04:00:00Z,2011,3,2011-03-31T04:00:00Z,,2011-04-20T16:01:00Z,2011-07560,0,0,0900006480c15845
FDA-2011-N-0003-0009,FDA,FDA-2011-N-0003,"New Animal Drugs: Amikacin Sulfate, Ampicillin Trihydrate, Ceftiofur Hydrochloride, Cephapirin Benzathine, etc.; Correcting Amendments",Rule,NCR-Notice of Correction,2011-03-29T04:00:00Z,2011,3,2011-03-29T04:00:00Z,,2011-03-29T13:29:20Z,2011-07313,0,0,0900006480c1279e
FDA-2011-N-0003-0007,FDA,FDA-2011-N-0003,New Animal Drugs: Oxytetracycline,Rule,NFR-Notice of Final Rule,2011-03-28T04:00:00Z,2011,3,2011-03-28T04:00:00Z,,2011-03-28T14:44:26Z,2011-07216,0,0,0900006480c11e79
FDA-2011-N-0003-0008,FDA,FDA-2011-N-0003,New Animal Drugs: Arsanilate Sodium; Sulfaethoxypyridazine,Rule,NFR-Notice of Final Rule,2011-03-28T04:00:00Z,2011,3,2011-03-28T04:00:00Z,,2011-03-28T14:56:22Z,2011-07214,0,0,0900006480c11e7a
FDA-2011-N-0003-0006,FDA,FDA-2011-N-0003,"Tolerances for Residues of New Animal Drugs in Food: 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters, etc.; Correcting Amendments",Rule,NFR-Notice of Final Rule,2011-03-25T04:00:00Z,2011,3,2011-03-25T04:00:00Z,,2011-03-25T15:07:49Z,2011-06796,0,0,0900006480c10d09
FDA-2010-N-0002-0095,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor's Name and Address; Corrections,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:39:40Z,2011-6795,0,0,0900006480c0f8fd
FDA-2010-N-0002-0097,FDA,FDA-2010-N-0002,"Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of  New Animal Drug Applications; Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran; Roxarsone; Correction",Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:46:28Z,2011-6790,0,0,0900006480c0fd1e
FDA-2010-N-0002-0096,FDA,FDA-2010-N-0002,New Animal Drugs for Use in Animal Feeds: Florfenicol; Correction,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:42:25Z,2011-6789,0,0,0900006480c0fd16
FDA-2010-N-0002-0098,FDA,FDA-2010-N-0002,Certain Other Dosage Form New Animal Drugs: Detomidine; Correction,Rule,NCR-Notice of Correction,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2011-03-24T13:48:54Z,2011-06791,0,0,0900006480c0fd2a
FDA-2011-N-0026-0001,FDA,FDA-2011-N-0026,Medical Devices; Immunology and Microbiology Devices: Classification of Ovarian Adnexal Mass Assessment Score Test System,Rule,NFR-Notice of Final Rule,2011-03-23T04:00:00Z,2011,3,,,2011-03-23T19:40:15Z,2011-06620,0,0,0900006480c0ec97
FDA-2002-F-0198-0007,FDA,FDA-2002-F-0198,Food Additives Permitted for Direct Addition to Food for Human Consumption: Bacteriophage Preparation,Rule,NFR-Notice of Final Rule,2011-03-23T04:00:00Z,2011,3,2011-03-23T04:00:00Z,,2011-03-23T16:07:13Z,2011-06792,0,0,0900006480c0ed08
FDA-1999-F-0056-0004,FDA,FDA-1999-F-0056,"Irradiation in the Production, Processing, and Handling of Food",Rule,NCD-Notice of Confirmation of Effective Date,2011-03-22T04:00:00Z,2011,3,2011-03-22T04:00:00Z,,2011-03-22T14:06:19Z,2011-06625,0,0,0900006480c0d376
FDA-2011-N-0130-0001,FDA,FDA-2011-N-0130,Investigational New Drug Applications and Abbreviated New Drug Applications,Rule,NFR-Notice of Final Rule,2011-03-15T04:00:00Z,2011,3,2011-03-15T04:00:00Z,,2011-03-15T18:33:35Z,2011-05946,0,0,0900006480c07efc
FDA-2011-N-0101-0001,FDA,FDA-2011-N-0101,Requests for Exemption From the Bar Code Label Requirements; Change of Address,Rule,NFR-Notice of Final Rule,2011-03-09T05:00:00Z,2011,3,2011-03-09T05:00:00Z,,2011-03-09T19:06:33Z,2011-05288,0,0,0900006480c04017
FDA-2011-N-0003-0004,FDA,FDA-2011-N-0003,Oral Dosage Form New Animal Drugs: Spinosad and Milbemycin Oxime,Rule,NFR-Notice of Final Rule,2011-03-08T05:00:00Z,2011,3,2011-03-08T05:00:00Z,,2011-03-08T16:02:16Z,2011-05144,0,0,0900006480c0323d
FDA-2010-N-0560-0004,FDA,FDA-2010-N-0560,Amendments to General Regulations of the Food and Drug Administration,Rule,NFR-Notice of Final Rule,2011-03-08T05:00:00Z,2011,3,2011-03-08T05:00:00Z,,2011-06-11T16:28:38Z,2011-05147,0,0,0900006480c032bb
FDA-2007-N-0265-0005,FDA,FDA-2007-N-0265,Temperature-Indicating Devices: Thermally Processed Low-Acid Foods Packaged in Hermetically Sealed Containers,Rule,NFR-Notice of Final Rule,2011-03-03T05:00:00Z,2011,3,2011-03-03T05:00:00Z,,2011-03-03T14:17:30Z,2011-04475,0,0,0900006480bfe0cb
FDA-2010-N-0534-0003,FDA,FDA-2010-N-0534,New Animal Drugs for Minor Use and Minor Species; Confirmation of Effective Date,Rule,NCD-Notice of Confirmation of Effective Date,2011-03-02T05:00:00Z,2011,3,2011-03-02T05:00:00Z,,2011-06-11T16:28:38Z,2011-04593,0,0,0900006480bfcc1c
FDA-2010-F-0200-0002,FDA,FDA-2010-F-0200,Secondary Direct Food Additives Permitted in Food for Human Consumption,Rule,NFR-Notice of Final Rule,2011-03-02T05:00:00Z,2011,3,2011-03-02T05:00:00Z,2011-04-02T03:59:59Z,2011-03-02T16:42:43Z,2011-04497,0,0,0900006480bfcbd5
FDA-2008-N-0106-0032,FDA,FDA-2008-N-0106,Medical Devices; Medical Device Data Systems,Rule,NFR-Notice of Final Rule,2011-02-15T05:00:00Z,2011,2,2011-02-15T05:00:00Z,,2011-04-11T16:53:32Z,2011-03321,0,0,0900006480bef5e2
FDA-2009-F-0525-0005,FDA,FDA-2009-F-0525,Food Additives Permitted in Feed and Drinking Water of Animals: Formic Acid,Rule,NFR-Notice of Final Rule,2011-02-09T05:00:00Z,2011,2,2011-02-09T05:00:00Z,2011-03-12T04:59:59Z,2011-02-09T14:41:31Z,2011-02789,0,0,0900006480beaac9
FDA-2010-D-0645-0002,FDA,FDA-2010-D-0645,Medical Devices: General and Plastic Surgery Devices; Classification of Contact Cooling System for Aesthetic Use,Rule,NFR-Notice of Final Rule,2011-02-07T05:00:00Z,2011,2,2011-02-07T05:00:00Z,,2011-02-07T15:41:57Z,2011-02552,0,0,0900006480bdd15e
FDA-2011-N-0003-0001,FDA,FDA-2011-N-0003,New Animal Drugs: Masitinib,Rule,NFR-Notice of Final Rule,2011-02-04T05:00:00Z,2011,2,2011-02-04T05:00:00Z,,2011-02-04T15:32:40Z,2011-2519,0,0,0900006480bdbad8
FDA-2010-N-0002-0092,FDA,FDA-2010-N-0002,Implantation or Injectable Dosage Form New Animal Drugs: Oxytetracycline and Flunixin,Rule,NFR-Notice of Final Rule,2011-01-20T05:00:00Z,2011,1,2011-01-20T05:00:00Z,,2011-01-20T14:05:26Z,2011-01040,0,0,0900006480bce9e7
FDA-2010-N-0002-0091,FDA,FDA-2010-N-0002,New Animal Drugs: Change of Sponsor,Rule,NFR-Notice of Final Rule,2011-01-18T05:00:00Z,2011,1,2011-01-18T05:00:00Z,,2011-01-18T14:54:02Z,2011-904,0,0,0900006480bcce2d
FDA-2010-N-0002-0090,FDA,FDA-2010-N-0002,New Animal Drugs: Follicle Stimulating Hormone; Change of Sponsor,Rule,NFR-Notice of Final Rule,2011-01-18T05:00:00Z,2011,1,2011-01-18T05:00:00Z,,2011-01-18T14:51:10Z,2011-909,0,0,0900006480bccd28
FDA-2009-N-0592-0069,FDA,FDA-2009-N-0592,Informed Consent Elements,Rule,NFR-Notice of Final Rule,2011-01-04T05:00:00Z,2011,1,2011-01-04T05:00:00Z,,2011-06-11T16:28:13Z,2010-33193,0,0,0900006480bc4ae4